Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone versus hydrochlorothiazide with furosemide for refractory edema in heart failure
IRCT20111206008307N35Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metolazone, hydrochlorothiazide and furosemide in heart failure (HF) and edema (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Edema, Fluid input/output and 2 more. Started Nov 2019; status: completed.
02
Drugs
metolazonehydrochlorothiazidefurosemide
03
Conditions
heart failure (HF)edema
Beyond the preview
Go deeper on IRCT20111206008307N35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N35.